Suchergebnisse - "Brown, Samuel M"

PubPharm (395)

51

Effectiveness of Monovalent mRNA Vaccines Against COVID-19-Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States - IVY Network, 18 States, December 26, 2021-August 31, 2022

enthalten in: MMWR. Morbidity and mortality weekly report | 2022

von Surie, D. | Bonnell, L. | Adams, K. | +151

52

Vaccine effectiveness of primary series and booster doses against covid-19 associated hospital admissions in the United States : living test negative design study

enthalten in: BMJ (Clinical research ed.) | 2022

von Adams, K. | Rhoads, J. | Surie, D. | +138

UpdateOf: medRxiv. 2022 Jun 14;:. - PMID 35734090

53

Tixagevimab-cilgavimab for treatment of patients hospitalised with COVID-19 : a randomised, double-blind, phase 3 trial

enthalten in: The Lancet. Respiratory medicine | 2022

von ACTIV-3–Therapeutics for Inpatients with COVID-19 (TICO) Study Group | Ginde, A. | Paredes, R. | +98

CommentIn: Lancet Respir Med. 2022 Oct;10(10):928-930. - PMID 35817073

54

Effectiveness of the Ad26.COV2.S (Johnson & Johnson) Coronavirus Disease 2019 (COVID-19) Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2022

von Lewis, N. | Self, W. | Gaglani, M. | +54

55

Oxygen-Free Days as an Outcome Measure in Clinical Trials of Therapies for COVID-19 and Other Causes of New-Onset Hypoxemia

enthalten in: Chest | 2022

von Moskowitz, A. | Shotwell, M. | Gibbs, K. | +21

CommentIn: Chest. 2023 Nov;164(5):e157-e158. - PMID 37945201

56

Evaluating Primary Endpoints for COVID-19 Therapeutic Trials to Assess Recovery

enthalten in: American journal of respiratory and critical care medicine | 2022

von Douin, D. | Siegel, L. | Grandits, G. | +27

CommentIn: Am J Respir Crit Care Med. 2022 Sep 15;206(6):659-660. - PMID 35608532

57

mRNA Vaccine Effectiveness Against Coronavirus Disease 2019 Hospitalization Among Solid Organ Transplant Recipients

enthalten in: The Journal of infectious diseases | 2022

von Kwon, J. | Tenforde, M. | Gaglani, M. | +52

58

Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial

enthalten in: Annals of internal medicine | 2022

von ACTIV-3/TICO Study Group | Barkauskas, C. | Mylonakis, E. | +98

CommentIn: Ann Intern Med. 2023 Feb;176(2):eL220455. - PMID 36802894

59

What Next? New Drugs, Old Drugs, and New Challenges in Choosing Treatments for Covid-19

enthalten in: NEJM evidence | 2022

von Peltan, I. | Brown, S.

60

Efficacy and Safety of Sarilumab in Hospitalized Patients With Coronavirus Disease 2019 : A Randomized Clinical Trial

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2022

von Sivapalasingam, S. | Lederer, D. | Bhore, R. | +37